Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
State drug caps associated with fewer Medicaid-covered prescriptions for opioid use disorder, 2017-2022.
Health Aff Sch
December 2024
Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN 37203, United States.
The Medicaid program is the largest payer of opioid use disorder (OUD) treatment, including medications for OUD (MOUD). Because of budget neutrality requirements, some Medicaid programs use prescription drug caps to limit the monthly number of prescriptions an enrollee can fill. This study examined the association between Medicaid prescription drug caps and Medicaid-covered prescriptions for 2 forms of MOUD (buprenorphine and naltrexone) from 2017 to 2022 using fee-for-service and managed care data from Medicaid's State Drug Utilization Data.
View Article and Find Full Text PDFDallas Nephrology Associates' journey to value-based care.
Am J Manag Care
December 2024
Dallas Nephrology Associates, 1505 LBJ Freeway, Dallas, TX 75234. Email:
Objectives: In 2016, Dallas Nephrology Associates recognized that the economic, humanistic, and societal burden of end-stage kidney disease was unsustainable and the fee-for-service model of reimbursement did not support a value-based care approach. We decided to be proactive by creating new workflows, education, and disease management so that patients could make well-informed choices, ultimately resulting in better outcomes.
Methods: Our shift toward value-based care focused on patient engagement, education, integrated infrastructure, collaboration, and monitoring of metrics associated with improved outcomes.
What does it cost to expand two-way texting for post-operative follow-up? A cost analysis in routine voluntary medical male circumcision settings in South Africa.
medRxiv
November 2024
International Training and Education Center for Health (I-TECH), Seattle, WA, United States of America.
Up to 98% of adult voluntary medical male circumcision (VMMC) clients heal without adverse events (AEs) in South Africa and in the sub-Saharan Africa (SSA) region, yet all clients in South Africa (SA) are still required to attend in-person reviews, creating added work for providers and barriers for clients. A randomized controlled trial (RCT) using our fee-free, open-source, two-way texting (2wT) approach showed that males could independently monitor their healing with support from VMMC nurse-led telehealth and that 2wT was more cost-effective than routine visits for quality post-operative monitoring. The objectives of this costing activity were to assess the additive cost of 2wT vs.
View Article and Find Full Text PDFUse of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.
J Comp Eff Res
January 2025
Medical Oncology Department, Program in Solid Tumours, CIMA, Cancer Center Clínica Universidad de Navarra, Madrid, and Grupo Español de Investigación en Cancer ginecológicO (GEICO), Madrid, 28027, Spain.
Article Synopsis
- The study analyzes the cost differences in managing hematologic adverse events (AEs) for the individualized starting dose (ISD) versus the fixed starting dose (FSD) of niraparib from a US payer perspective.
- Data from a phase III trial provided AE occurrence rates, and costs were calculated based on 2020 adjustments from a healthcare database.
- Results showed that managing AEs was significantly cheaper with ISD ($6744.93) compared to FSD ($12,987.71), suggesting ISD not only cuts costs but also improves patient safety.
Cost Savings in Chronic Pain Patients Initiating Peripheral Nerve Stimulation (PNS) with a 60-Day PNS Treatment.
Pain Ther
November 2024
SPR Therapeutics, Cleveland, OH, USA.
Article Synopsis
- This study examines the financial effects on healthcare payers of using 60-day peripheral nerve stimulation (60-Day PNS) compared to a conventional brief trial (PNS-BT) for chronic pain patients.
- Analysis of Medicare data revealed that patients starting with 60-Day PNS had lower costs and fewer complications when progressing to permanent implants compared to those starting with PNS-BT.
- Overall, the 60-Day PNS approach is more cost-effective, resulting in lower costs per successful treatment outcome for chronic pain management.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!